Clinical Trials
2 trialsNCT03186404 2022-02-08
SPARE-HF
University Health Network, Toronto
Phase 2 Unknown
NCT01525407 2017-08-17
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Fred Hutchinson Cancer Center
Phase 2 Completed